COX20 Inhibitors, through their interaction with various components of the cellular and mitochondrial pathways, lead to an indirect inhibition of COX20 activity. For instance, mitoquinone mesylate mitigates oxidative stress within the mitochondria, which can decrease the need for COX20's chaperone activity, as the assembly of COX is less critical under reduced oxidative conditions. Similarly, oligomycin, by thwarting ATP synthase, creates an energy deficit that may lessen the requirement for COX assembly and thus COX20 activity. Compounds like Potassium cyanide, azide, and carbon monoxide directly inhibit COX activity by binding to its heme groups, which could render the assistance of COX20 in COX assembly superfluous. Antimycin A's action on complex III and rotenone's on complex I both contribute to a decrease in the electron transport chain's efficiency, which in turn could diminish the need for COX20's role in facilitating COX complex assembly due to lower electron flow and ATP demand.
Furthermore, chemical inhibitors that disrupt mitochondrial biogenesis or function can indirectly diminish COX20's rolein cytochrome c oxidase assembly. Chloramphenicol and tetracycline, by inhibiting mitochondrial protein synthesis, hinder the production of mitochondrial-encoded COX subunits, which could reduce the necessity for COX20's chaperone function. Zidovudine's impact on mitochondrial DNA replication may also lead to a decrease in COX subunit production. Meanwhile, allopurinol reduces reactive oxygen species production, potentially lessening the protective role of COX20, as there is a decreased need for its involvement in preventing oxidative damage during COX assembly. Tenovin-6, through inhibition of sirtuins, could lead to increased acetylation of mitochondrial proteins, which might indirectly affect COX20's function by altering the assembly dynamics of the COX complex. Collectively, these inhibitors create conditions that lead to a decreased functional demand for COX20, effectively inhibiting its activity without directly targeting the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mito-Q | 444890-41-9 | sc-507441 | 5 mg | $290.00 | ||
As a mitochondria-targeted antioxidant, mitoquinone mesylate decreases oxidative stress, potentially diminishing COX20 function by reducing the necessity for its chaperone activity in the assembly of cytochrome c oxidase (COX). | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
This macrolide binds to subunit c of the F0 complex of ATP synthase, inhibiting ATP synthesis. This stress may indirectly decrease COX20 involvement by impairing COX assembly due to ATP deficit. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Azide specifically inhibits cytochrome c oxidase by binding to the heme group in complex IV. This could result in a reduced functional demand for COX20 due to the inhibited enzyme activity. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Antimycin A binds to cytochrome b and blocks electron transfer in complex III. This disruption could lead to diminished COX20 function due to a reduced requirement for COX assembly maintenance. | ||||||
Tenovin-6 | 1011557-82-6 | sc-224296 sc-224296A | 1 mg 5 mg | $272.00 $1214.00 | 9 | |
This small molecule acts as a SIRT1 and SIRT2 inhibitor, which may lead to increased acetylation of mitochondrial proteins and potentially diminish COX20 function through indirect effects on COX assembly and stability. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
As an inhibitor of mitochondrial protein synthesis, chloramphenicol can lead to diminished COX20 function by reducing the synthesis of mtDNA-encoded COX subunits, hence impacting its assembly role. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline inhibits mitochondrial protein synthesis, thereby possibly diminishing COX20's function by impeding the assembly of COX subunits. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
Can cause mitochondrial toxicity, including inhibition of mitochondrial DNA polymerase. This could lead to diminished COX20 function by affecting the biosynthesis of COX subunits. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol is a xanthine oxidase inhibitor that can lead to reduced production of reactive oxygen species. This reduction potentially diminishes the protective chaperone function of COX20 in assembling COX. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone is an inhibitor of mitochondrial complex I, leading to a decrease in electron flow and subsequent ATP production. This may reduce COX20's function indirectly due to less demand for COX assembly under energy stress. | ||||||